๐ข ๐๐จ๐ฆ๐ง ๐๐ก: $Tempus AI(TEM.US) Tempus AI Launches OneOme Pharmacogenomics Testing Nationwide
๐ ๐๐ฒ๐ ๐๐ถ๐ด๐ต๐น๐ถ๐ด๐ต๐๐:โค ๐ง๐ฒ๐บ๐ฝ๐๐ ๐๐ launches ๐ข๐ป๐ฒ๐ข๐บ๐ฒ pharmacogenomics testing nationwide.โค Launch follows the company's ๐ก๐ผ๐๐ฒ๐บ๐ฏ๐ฒ๐ฟ ๐ฎ๐ฌ๐ฎ๐ฑ acquisition of OneOme.โค ๐ฅ๐ถ๐ด๐ต๐๐ ๐ฒ๐ฑ ๐๐ผ๐บ๐ฝ๐ฟ๐ฒ๐ต๐ฒ๐ป๐๐ถ๐๐ฒ analyzes ๐ฎ๐ณ inherited genes.โค Standalone ๐๐ฃ๐ฌ๐ and ๐จ๐๐ง๐ญ๐๐ญ pharmacogenomics tests are also available.โค Results are delivered in under ๐ฑ days on average.โค FDA updated fluoropyrimidine safety labeling to recommend ๐๐ฃ๐ฌ๐ testing.โค Study estimates nearly ๐ฏ๐ฌ% of patients experience severe or fatal toxicities.โค Testing is integrated with Tempus's tissue and liquid biopsy platform.โค Platform enables clinicians to evaluate ๐ฑ๐ฟ๐๐ด-๐ด๐ฒ๐ป๐ฒ interactions at the point of care.The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments